These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 32698410)

  • 1. Treatment of Patients with Advanced Biliary Tract Cancer with Either Oxaliplatin, Gemcitabine, and Capecitabine or Cisplatin and Gemcitabine-A Randomized Phase II Trial.
    Markussen A; Jensen LH; Diness LV; Larsen FO
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32698410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capecitabine plus Oxaliplatin as a Second-Line Therapy for Advanced Biliary Tract Cancers: A Multicenter, Open-Label, Phase II Trial.
    Kim ST; Oh SY; Lee J; Kang JH; Lee HW; Lee MA; Sohn BS; Hong JH; Park YS; Park JO; Lim HY
    J Cancer; 2019; 10(25):6185-6190. PubMed ID: 31772650
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of the Efficacy between Gemcitabine-Cisplatin and Capecitabine-Cisplatin Combination Chemotherapy for Advanced Biliary Tract Cancer.
    Lee J; Hong TH; Lee IS; You YK; Lee MA
    Cancer Res Treat; 2015 Apr; 47(2):259-65. PubMed ID: 25648099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.
    Weigt J; Malfertheiner P
    Expert Rev Gastroenterol Hepatol; 2010 Aug; 4(4):395-7. PubMed ID: 20678012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II study of capecitabine and cisplatin in previously untreated advanced biliary tract cancer.
    Hong YS; Lee J; Lee SC; Hwang IG; Choi SH; Heo JS; Park JO; Park YS; Lim HY; Kang WK
    Cancer Chemother Pharmacol; 2007 Aug; 60(3):321-8. PubMed ID: 17143602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal regimen of trastuzumab in combination with oxaliplatin/ capecitabine in first-line treatment of HER2-positive advanced gastric cancer (CGOG1001): a multicenter, phase II trial.
    Gong J; Liu T; Fan Q; Bai L; Bi F; Qin S; Wang J; Xu N; Cheng Y; Bai Y; Liu W; Wang L; Shen L
    BMC Cancer; 2016 Feb; 16():68. PubMed ID: 26857702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, Open-Label Phase II Study Comparing Capecitabine-Cisplatin Every 3 Weeks with S-1-Cisplatin Every 5 Weeks in Chemotherapy-Naïve Patients with HER2-Negative Advanced Gastric Cancer: OGSG1105, HERBIS-4A Trial.
    Kawakami H; Takeno A; Endo S; Makari Y; Kawada J; Taniguchi H; Tamura S; Sugimoto N; Kimura Y; Tamura T; Fujitani K; Sakai D; Shimokawa T; Kurokawa Y; Satoh T
    Oncologist; 2018 Dec; 23(12):1411-e147. PubMed ID: 30115736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy outcomes for the treatment of unresectable intrahepatic and hilar cholangiocarcinoma: a retrospective analysis.
    Eckmann KR; Patel DK; Landgraf A; Slade JH; Lin E; Kaur H; Loyer E; Weatherly JM; Javle M
    Gastrointest Cancer Res; 2011 Sep; 4(5-6):155-60. PubMed ID: 22295126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-World Evidence on Palliative Gemcitabine and Oxaliplatin (GemOx) Combination Chemotherapy in Advanced Biliary Tract Cancer.
    Lagenfelt H; Blomstrand H; Elander NO
    Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in the treatment of biliary tract cancers.
    Uson Junior PLS; Bogenberger J; Borad MJ
    Curr Opin Gastroenterol; 2020 Mar; 36(2):85-89. PubMed ID: 31972599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gemcitabine and capecitabine for advanced biliary cancer.
    Gabriel E; Gandhi S; Attwood K; Kuvshinoff B; Hochwald S; Iyer R
    J Gastrointest Oncol; 2017 Aug; 8(4):728-736. PubMed ID: 28890824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presentation and Outcomes with First-Line Chemotherapy in Advanced Cholangiocarcinomas-A Relatively Rare Component of Biliary Tract Cancers in India.
    Bhargava PG; Kumar A; Simha V; Shah M; Patkar S; Goel M; Ostwal V; Ramaswamy A
    South Asian J Cancer; 2020 Oct; 9(4):209-212. PubMed ID: 34268260
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of conversion surgery after chemotherapy in patients with initially unresectable and recurrent biliary tract cancer.
    Nakamura I; Hatano E; Baba H; Kamei K; Wada H; Shimizu J; Kanai M; Yoshimura K; Nagano H; Ioka T
    Ann Gastroenterol Surg; 2023 Nov; 7(6):1009-1020. PubMed ID: 37927929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment Response and Survival with Chemotherapy for Unresectable, Nonmetastatic Cholangiocarcinoma.
    Gupta A; Sahai P; Prasad M; Yadav HP; Srivastava G; Nakhro N; Kumar G; Sharma N
    Euroasian J Hepatogastroenterol; 2024; 14(1):5-8. PubMed ID: 39022199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter, single-arm, basket design, phase II study of NC-6004 plus gemcitabine in patients with advanced unresectable lung, biliary tract, or bladder cancer.
    Volovat SR; Ciuleanu TE; Koralewski P; Olson JEG; Croitoru A; Koynov K; Stabile S; Cerea G; Osada A; Bobe I; Volovat C
    Oncotarget; 2020 Aug; 11(33):3105-3117. PubMed ID: 32913555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcatheter arterial chemoembolization with gemcitabine and oxaliplatin for the treatment of advanced biliary tract cancer.
    Zhao Q; Qian S; Zhu L; Qu XD; Zhang W; Yan ZP; Cheng JM; Liu QX; Liu R; Wang JH
    Onco Targets Ther; 2015; 8():595-600. PubMed ID: 25792843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified FOLFIRINOX as a Second-Line Treatment for Patients with Gemcitabine-Failed Advanced Biliary Tract Cancer: A Prospective Multicenter Phase II Study.
    Lee YP; Oh SY; Kim KM; Go SI; Kim JH; Huh SJ; Kang JH; Ji JH
    Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gemcitabine and s-1 combination chemotherapy in patients with advanced biliary tract cancer: a retrospective study.
    Mita K; Ito H; Fukumoto M; Murabayashi R; Nabetani M; Koizumi K; Hayashi T
    Case Rep Oncol; 2010 Sep; 3(3):498-504. PubMed ID: 21611105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histological complete response in a patient with advanced biliary tract cancer treated by gemcitabine/cisplatin/S-1 combination chemotherapy: A case report.
    Matsubara T; Nishida T; Tomimaru Y; Yamamoto M; Hayashi S; Nakajima S; Fukui K; Dono K; Adachi S; Ioka T; Kanai M; Inada M
    Mol Clin Oncol; 2016 Dec; 5(6):757-761. PubMed ID: 28101354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bevacizumab based chemotherapy is a promising option in metastatic gallbladder adenocarcinoma.
    Aagre SV; Tonse M; Talele A; Sharma S; Advani SH
    Mol Clin Oncol; 2021 Aug; 15(2):153. PubMed ID: 34178324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.